AngioDynamics, Inc. (ANGO) Receives Consensus Rating of “Hold” from Brokerages

Shares of AngioDynamics, Inc. (NASDAQ:ANGO) have received a consensus rating of “Hold” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $18.60.

A number of research firms have weighed in on ANGO. Cantor Fitzgerald upped their price objective on shares of AngioDynamics from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, July 4th. KeyCorp reaffirmed a “hold” rating on shares of AngioDynamics in a research report on Friday, September 29th. Barclays PLC reduced their price target on shares of AngioDynamics from $17.00 to $16.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 19th. Canaccord Genuity reaffirmed a “hold” rating and set a $17.00 price target on shares of AngioDynamics in a research report on Tuesday, July 18th. Finally, Zacks Investment Research raised shares of AngioDynamics from a “sell” rating to a “hold” rating in a research report on Monday, August 14th.

Several hedge funds have recently modified their holdings of the company. State of Alaska Department of Revenue lifted its holdings in AngioDynamics by 91.7% in the second quarter. State of Alaska Department of Revenue now owns 6,768 shares of the medical instruments supplier’s stock worth $109,000 after acquiring an additional 3,238 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its holdings in AngioDynamics by 77.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock worth $123,000 after acquiring an additional 3,100 shares during the last quarter. Municipal Employees Retirement System of Michigan lifted its holdings in AngioDynamics by 3.0% in the first quarter. Municipal Employees Retirement System of Michigan now owns 7,200 shares of the medical instruments supplier’s stock worth $125,000 after acquiring an additional 210 shares during the last quarter. Mason Street Advisors LLC lifted its holdings in AngioDynamics by 8.5% in the first quarter. Mason Street Advisors LLC now owns 7,470 shares of the medical instruments supplier’s stock worth $130,000 after acquiring an additional 584 shares during the last quarter. Finally, Acrospire Investment Management LLC lifted its holdings in AngioDynamics by 3.7% in the second quarter. Acrospire Investment Management LLC now owns 8,915 shares of the medical instruments supplier’s stock worth $145,000 after acquiring an additional 317 shares during the last quarter. 94.79% of the stock is currently owned by institutional investors and hedge funds.

Shares of AngioDynamics (ANGO) traded down 0.64% during mid-day trading on Thursday, reaching $17.15. The company’s stock had a trading volume of 130,219 shares. The firm has a market capitalization of $629.66 million, a PE ratio of 173.23 and a beta of 1.12. The firm has a 50-day moving average of $17.44 and a 200-day moving average of $16.39. AngioDynamics has a 52 week low of $14.80 and a 52 week high of $18.85.

AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings data on Thursday, September 28th. The medical instruments supplier reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). The firm had revenue of $85.40 million during the quarter, compared to analysts’ expectations of $86.12 million. AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The business’s quarterly revenue was down 3.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.17 earnings per share. Equities research analysts forecast that AngioDynamics will post $0.66 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2017/10/26/angiodynamics-inc-ango-receives-consensus-rating-of-hold-from-brokerages.html.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Analyst Recommendations for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply